Skip to main content

Advertisement

SpringerLink
Log in

Newer Applications of Nuclear Cardiology in Systolic Heart Failure: Detecting Coronary Artery Disease and Guiding Device Therapy

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Radionuclide-based imaging techniques can be applied to the heart failure population to derive clinically useful information. This review discusses the specific role of myocardial perfusion imaging for determining heart failure etiology, and the potential application of radionuclide-based imaging techniques for the optimal selection of patients with heart failure for device therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Gheorghiade M, Sopko G, De Luca L, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006;114:1202–13.

    Article  PubMed  Google Scholar 

  2. Cleland JGF, Pennell DJ, Ray SG, et al. on behalf of the CHRISTMAS investigators: myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet. 2003;362:14–21.

    Article  PubMed  CAS  Google Scholar 

  3. Udelson JE, Shafer CD, Carrio I. Radionuclide imaging in heart failure: assessing etiology and outcomes and implications for management. J Nucl Cardiol. 2002;9:40S–52S.

    Article  PubMed  Google Scholar 

  4. Felker GM, Shaw LK, O’Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002;39:210–8.

    Article  PubMed  Google Scholar 

  5. • Soman P, Lahiri A, Mieres JH, et al.: Etiology and pathophysiology of new-onset heart failure: Evaluation by myocardial perfusion imaging. J Nucl Cardiol 2009;16:82–91. This prospective study explored the utility of myocardial perfusion imaging for the detection of causally related coronary artery disease in 201 patients hospitalized with new-onset heart failure, and demonstrated a high negative predictive value.

    Article  PubMed  Google Scholar 

  6. Daubert JP, Zareba W, Cannom DS, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357–65.

    Article  PubMed  Google Scholar 

  7. Moss AJ, Greenberg H, Case RB, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760–5.

    Article  PubMed  Google Scholar 

  8. Henderson EB, Kahn JK, Corbett JR, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation. 1988;78:1192–9.

    PubMed  CAS  Google Scholar 

  9. • Tamaki N, Yoshinaga K: Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J.Nucl.Cardiol. 2011;18:135–143. This is a review article describing the emerging utility of MIBG imaging of the cardiac sympathetic nervous system and β-methyl-p-iodophenyl-pentadecanoic acid imaging for ischemia.

    Article  PubMed  Google Scholar 

  10. Agostini D, Belin A, Amar MH, et al. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study. J Nucl Med. 2000;41:845–51.

    PubMed  CAS  Google Scholar 

  11. Yamada T, Shimonagata T, Fukunami M, et al. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study. J Am Coll Cardiol. 2003;41:231–8.

    Article  PubMed  Google Scholar 

  12. Katoh S, Shishido T, Kutsuzawa D, et al. Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction. Ann Nucl Med. 2010;24:679–86.

    Article  PubMed  Google Scholar 

  13. Merlet P, Benvenuti C, Moyse D, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med. 1999;40:917–23.

    PubMed  CAS  Google Scholar 

  14. •• Kuwabara Y, Tamaki N, Nakata T, et al.: Determination of the survival rate in patients with congestive heart failure stratified by (123)I-MIBG imaging: a meta-analysis from the studies performed in Japan. Ann.Nucl.Med. 2011;25:101–107. This meta-analysis of seven Japanese studies provided evidence that a decreased heart-to-mediastinal ratio and increased washout ratio in MIBG imaging was associated with a worse prognosis in patients with heart failure.

    Article  PubMed  Google Scholar 

  15. • Agostini D, Verberne HJ, Burchert W, et al.: I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur.J.Nucl.Med.Mol.Imaging 2008;35:535–546. This multicenter retrospective analysis provided further evidence that MIBG imaging can be used to predict major adverse cardiovascular events (cardiac death, heart transplant, or potentially fatal arrhythmia). Patients with a low heart-to-mediastinal ratio had a significantly worse 2-year event-free survival.

    Article  PubMed  Google Scholar 

  16. Nishisato K, Hashimoto A, Nakata T, et al. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs. J Nucl Med. 2010;51:1241–9.

    Article  PubMed  Google Scholar 

  17. •• Jacobson AF, Senior R, Cerqueira MD, et al.: Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J.Am.Coll.Cardiol. 2010;55:2212–2221. This prospective trial of patients with heart failure undergoing MIBG imaging validated prior studies showing the prognostic utility of imaging with this radiotracer.

    Article  PubMed  Google Scholar 

  18. Bax JJ, Kraft O, Buxton AE, et al. 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging. 2008;1:131–40.

    Article  PubMed  Google Scholar 

  19. Boogers MJ, Borleffs CJ, Henneman MM, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55:2769–77.

    Article  PubMed  Google Scholar 

  20. • Epstein AE, DiMarco JP, Ellenbogen KA, et al.: ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J.Am.Coll.Cardiol. 2008;51:e1-62. These are the ACC/AHA/HRS guidelines for device-based therapy.

    Article  PubMed  Google Scholar 

  21. Abraham WT, Fisher WG, Smith AL, et al. The miracle study group: cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–53.

    Article  PubMed  Google Scholar 

  22. Cleland JGF, Daubert JC, Erdmann E, et al. For the cardiac resynchronization-heart failure (Care-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.

    Article  PubMed  CAS  Google Scholar 

  23. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873–80.

    Article  PubMed  CAS  Google Scholar 

  24. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of medical therapy PaDiHFCI. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50.

    Article  PubMed  CAS  Google Scholar 

  25. Leclercq C, Faris O, Tunin R, et al. Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation. 2002;106:1760–3.

    Article  PubMed  Google Scholar 

  26. Blendea D, Singh JP. Lead positioning strategies to enhance response to cardiac resynchronization therapy. Heart Fail. Rev. 2010. doi:10.1007/s10741-010-9212-4.

  27. Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834–40.

    Article  PubMed  Google Scholar 

  28. Bax JJ, Marwick TH, Molhoek SG, et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol. 2003;92:1238–40.

    Article  PubMed  Google Scholar 

  29. Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol. 2002;40:1615–22.

    Article  PubMed  Google Scholar 

  30. Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117:2608–16.

    Article  PubMed  Google Scholar 

  31. Kerwin WF, Botvinick EH, O’Connell JW, et al. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol. 2000;35:1221–7.

    Article  PubMed  CAS  Google Scholar 

  32. Toussaint JF, Lavergne T, Kerrou K, et al. Basal asynchrony and resynchronization with biventricular pacing predict long-term improvement of LV function in heart failure patients. Pacing Clin Electrophysiol. 2003;26:1815–23.

    Article  PubMed  Google Scholar 

  33. • Adelstein EC, Saba S: Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J 2007;153:105–112. This is a retrospective analysis of patients who underwent CRT and nuclear imaging with thalium-201. A higher scar burden, large number of severely scarred segments, and scar near the LV lead tip was associated with a worse prognosis.

    Article  PubMed  Google Scholar 

  34. Chen J, Garcia EV, Folks RD, et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol. 2005;12:687–95.

    Article  PubMed  Google Scholar 

  35. • Chen J, Henneman MM, Trimble MA, et al.: Assessment of left ventricular mechanical dyssynchrony by phase analysis of ECG-gated SPECT myocardial perfusion imaging. J Nucl Cardiol 2008;15:127–136. This is a review of the technique of phase analysis of gated SPECT to measure LV dyssynchrony. The article also discusses how this method compares to echocardiographic measures of dyssynchrony and gives an overview of studies showing its use to predict response to CRT.

    Article  PubMed  Google Scholar 

  36. • Trimble MA, Velazquez EJ, Adams GL, et al.: Repeatability and reproducibility of phase analysis of gated single-photon emission computed tomography myocardial perfusion imaging used to quantify cardiac dyssynchrony. Nucl.Med.Commun. 2008;29:374–381. The repeatability and reproducibility of phase analysis of gated SPECT was analyzed in this study. This method is highly reproducible, with an interobserver correlation coefficient of 0.99 and an intraobserver correlation coefficient of 0.99 for both phase standard deviation and histogram bandwidth.

    Article  PubMed  Google Scholar 

  37. Henneman MM, Chen J, Ypenburg C, et al. Phase analysis of gated myocardial perfusion single-photon emission computed tomography compared with tissue doppler imaging for the assessment of left ventricular dyssynchrony. J Am Coll Cardiol. 2007;49:1708–14.

    Article  PubMed  Google Scholar 

  38. Trimble MA, Borges-Neto S, Smallheiser S, et al. Evaluation of left ventricular mechanical dyssynchrony as determined by phase analysis of ECG-gated SPECT myocardial perfusion imaging in patients with left ventricular dysfunction and conduction disturbances. J Nucl Cardiol. 2007;14:298–307.

    Article  PubMed  Google Scholar 

  39. •• Pazhenkottil AP, Buechel RR, Husmann L, et al.: Long-term prognostic value of left ventricular dyssynchrony assessment by phase analysis from myocardial perfusion imaging. Heart 2011;97:33–37. This prospective trial included consecutive patients undergoing gated SPECT and followed for an average of 3.2 years. LV dyssynchrony assessed by phase analysis of gated SPECT was shown to be a strong independent predictor of major adverse cardiovascular events.

    Article  PubMed  Google Scholar 

  40. Aljaroudi W, Aggarwal H, Venkataraman R, et al. Impact of left ventricular dyssynchrony by phase analysis on cardiovascular outcomes in patients with end-stage renal disease. J Nucl Cardiol. 2010;17:1058–64.

    Article  PubMed  Google Scholar 

  41. Boogers MJ, Chen J, van Bommel RJ, et al. Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging. 2011;38:230–8.

    Article  PubMed  Google Scholar 

  42. Friehling M, Chen J, Lin X, et al. A novel, gated-SPECT based protocol to determine changes in LV synchrony following CRT. J Nucl Cardiol. 2010;4:746. Abstract.

    Google Scholar 

Download references

Disclosures

Dr. M. Friehling: none. Dr. Prem Soman has served as a consultant for GE Healthcare and Astellas Pharma.

Author information

Authors and Affiliations

  1. University of Pittsburgh Medical Center Cardiovascular Institute, Presbyterian University Hospital, A-429 Scaife Hall, 200 Lothrop Street, Pittsburgh, PA, 15213, USA

    Mati Friehling & Prem Soman

Authors
  1. Mati Friehling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prem Soman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prem Soman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Friehling, M., Soman, P. Newer Applications of Nuclear Cardiology in Systolic Heart Failure: Detecting Coronary Artery Disease and Guiding Device Therapy. Curr Heart Fail Rep 8, 106–112 (2011). https://doi.org/10.1007/s11897-011-0057-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-011-0057-5

Keywords

Search

Navigation